Peptide stacks · Growth hormone

CJC-1295 and ipamorelin stack: what’s in it and the evidence

Checked against our library and study pagesPublished by PepVault

The CJC-1295 and ipamorelin stack is a blend of two compounds, CJC-1295 no DAC and ipamorelin, that the peptide community runs for growth hormone and body composition. The vial the library records holds 10 mg of powder in all: 5 mg each of CJC-1295 no DAC and ipamorelin.

This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.

What’s in the CJC-1295 and ipamorelin stack

The two parts of the CJC-1295 and ipamorelin stack
PartAmountWhat it’s there forEvidence (library)
CJC-1295 no DAC5 mg in the vial; 100–200 mcg per dose reportedGHRH analogue — pulsatile GH release, short half-life, stacks cleanly with GHRPsModerate
Ipamorelin5 mg in the vial; 200–300 mcg per dose reportedSelective GHRP — GH pulse without cortisol or prolactin rises in animal studiesModerate

What the 10 mg vial holds, part by part

  • CJC-1295 no DAC5 mg

  • Ipamorelin5 mg

Each bar is one part’s share of the powder in the vial the library records for the CJC-1295 and ipamorelin stack.

CJC-1295 no DAC

In the CJC-1295 and ipamorelin stack, CJC-1295 no DAC is listed for “GHRH analogue — pulsatile GH release, short half-life, stacks cleanly with GHRPs”. The shorter-acting version of CJC-1295, meant to give sharp, pulse-like GH release.

Ipamorelin

In the CJC-1295 and ipamorelin stack, ipamorelin is listed for “Selective GHRP — GH pulse without cortisol or prolactin rises in animal studies”. Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.

A smiling man in a navy t-shirt at his garage gym, a towel over his shoulder, holding his phone

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Has the CJC-1295 and ipamorelin stack been studied as a combination?

None of our 436 study pages tested CJC-1295 no DAC and ipamorelin together, so the CJC-1295 and ipamorelin stack rests on studies of its parts and on community reports.

What the library says about the evidence for the CJC-1295 and ipamorelin stack

This GHRH-analog + ghrelin-agonist pairing is reported to produce a roughly 3-5x larger GH pulse than either alone by acting on different pituitary receptors; it lacks formal combination safety trials but is widely described as well tolerated. CJC-1295 with DAC raised GH 2- to 10-fold for 6+ days after one injection (Teichman 2006); the no-DAC form used in this stack hasn't been studied in humans, and no trial has tested this specific combination. The foundational GH stack: CJC-1295 amplifies each GH pulse and ipamorelin triggers it without raising cortisol (in animal studies), so together they give a larger GH response than either alone.

The studies of the parts, one by one: 0 study pages on CJC-1295 no DAC (0 in people) and 10 study pages on ipamorelin (1 in people).

Our study pages on each part of the CJC-1295 and ipamorelin stack
PartStudy pagesIn peopleStrongest study page
CJC-1295 no DAC00None yet
Ipamorelin101Ipamorelin did not speed first meal after bowel surgery vs placebo (randomized trial, 2014)

What people commonly report on the CJC-1295 and ipamorelin stack

Commonly reported: deeper sleep, recovery and body composition. Deeper sleep and better recovery than either alone.

These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.

Why these are combined

The library gives two reasons for combining the parts of the CJC-1295 and ipamorelin stack:

  • GHRH and GHRP signals together gave a larger GH pulse than either alone in human studies of related peptides (Bowers 1990); the dual signal matches how the pituitary is normally driven.
  • In animal studies Ipamorelin triggered GH without raising cortisol or prolactin (human data cover GH only), so the pulse stays clean; water retention, tingling and glucose effects still apply.

From the library’s notes on the CJC-1295 and ipamorelin stack

The most widely used GH secretagogue pair: CJC-1295 no DAC (Mod GRF 1-29) gives the GHRH signal and Ipamorelin the GHRP signal. Pre-sleep and fasted-morning doses are most popular, and a high-fat meal within about 2 hours is commonly reported to blunt the pulse.

“CJC-1295 + Ipamorelin is the clean GH pulse”, the library’s note on the pair (clinical data)

CJC-1295 (no DAC) raises the GH baseline; Ipamorelin triggers a sharp, selective pulse without spiking cortisol or prolactin like older secretagogues. Timing matters more here than dose — fasted, before bed or post-workout, away from food (insulin + carbs blunt the pulse). The pairing mimics a natural release curve, which is the whole point of running them together.

“The core GH stack”, the Ipamorelin entry’s note (community report)

Mechanism: a GHRH (CJC) plus a GHRP (Ipa) releases more GH than the sum of each alone, a synergy well established for the drug classes in general.

“The core GH stack”, the CJC-1295 no DAC entry’s note (community report)

Mechanism: a GHRH analog (CJC) plus a GHRP (Ipa) releases more GH than the sum of each alone, a synergy well established for the two drug classes. CJC-1295 with DAC raised GH 2- to 10-fold (Teichman 2006); the no-DAC form hasn't been measured in humans.

How a the CJC-1295 and ipamorelin stack vial is mixed and measured

The vial the library records for the CJC-1295 and ipamorelin stack holds 10 mg of powder, mixed with 2 mL of bacteriostatic water. Every part dissolves into the same water, so each mL holds 2.5 mg of CJC-1295 no DAC and 2.5 mg of ipamorelin.

The CJC-1295 and ipamorelin stack’s vial with 2 mL of water, part by part
PartIn the vialSharePer mLIn 10 units (0.1 mL)
CJC-1295 no DAC5 mg50%2.5 mg250 mcg
Ipamorelin5 mg50%2.5 mg250 mcg

The ratio is fixed at 1 to 1 (CJC-1295 no DAC and ipamorelin), so a draw that holds more of one part holds more of all of them; a pre-mixed vial can’t change one part on its own.

The arithmetic only divides what the vial holds by the water it is mixed with; it says nothing about what amount anyone should take.

Compared with running the parts apart

What the library says about the CJC-1295 and ipamorelin stack against its parts on their own:

  • Usually sourced as separate vials and drawn into one syringe.
  • Commonly reported: SubQ 2–3x daily, fasted or before sleep, with both peptides drawn into one syringe just before injecting; cycles of 8–12 weeks, then 4 weeks off.
  • GHRH and GHRP signals together gave a larger GH pulse than either alone in human studies of related peptides (Bowers 1990); the dual signal matches how the pituitary is normally driven.
  • The classic GH stack: CJC-1295 amplifies each GH pulse and ipamorelin triggers it, so together they give a larger pulse than either alone, without the cortisol rise of other GHRPs.
  • Users commonly co-inject them from one syringe; no compatibility study has been published.
  • Almost always stacked with Ipamorelin: together they release more GH than either alone, a synergy well established for the two drug classes.

Safety notes

The library’s combination safety note on the CJC-1295 and ipamorelin stack

The combined GH/IGF-1 elevation makes the individual considerations additive — transient water retention, flushing, tingling, and possible reductions in insulin sensitivity — so glucose/IGF-1 monitoring is a reasonable clinician discussion. Ipamorelin's selectivity (shown in animal studies) means cortisol/prolactin are not expected to rise.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Questions people ask

What is in the CJC-1295 and ipamorelin stack?

The CJC-1295 and ipamorelin stack is a blend of two compounds, CJC-1295 no DAC and ipamorelin, that the peptide community runs for growth hormone and body composition. The vial the library records holds 10 mg of powder in all: 5 mg each of CJC-1295 no DAC and ipamorelin.

Has the CJC-1295 and ipamorelin stack been studied together?

Not as a combination in any of our study pages: the CJC-1295 and ipamorelin stack rests on studies of its parts and on community reports. From the library: This GHRH-analog + ghrelin-agonist pairing is reported to produce a roughly 3-5x larger GH pulse than either alone by acting on different pituitary receptors; it lacks formal combination safety trials but is widely described as well tolerated.

What do people report on the CJC-1295 and ipamorelin stack?

Commonly reported: deeper sleep, recovery and body composition. These are reports from people who run it.

How is a the CJC-1295 and ipamorelin stack vial measured?

The vial the library records holds 10 mg with 2 mL of water, at a fixed ratio, so one draw carries every part; the reconstitution calculator works out the units for a vial.

What does each part of the CJC-1295 and ipamorelin stack do?

The library lists CJC-1295 no DAC for “GHRH analogue — pulsatile GH release, short half-life, stacks cleanly with GHRPs” and ipamorelin for “Selective GHRP — GH pulse without cortisol or prolactin rises in animal studies”.

How does the CJC-1295 and ipamorelin stack compare with taking the parts separately?

From the library: Usually sourced as separate vials and drawn into one syringe.

More on these compounds

Track it in the app

PepVault for iPhone

Track your stack in PepVault

Log every compound in a stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo